Term
|
Definition
describes the interaction between a drug and a receptor, which produces a biochemical and/or physiological response |
|
|
Term
|
Definition
A receptor is a small area of a macromolecule (mostly protein, but can be nucleic acids) on or in a cell. Upon stimulation, specific biochemical and /or physiological responses occur |
|
|
Term
Sequence of
REC
® CHANNEL |
|
Definition
NT/H/DRUG->REC->CHANNEL OPENING -> FLOW OF ELECTROLYTES -> RESPONSE |
|
|
Term
Sequence of
REC
® SECOND MESSENGER SYSTEM |
|
Definition
NT, H or DRUG->REC->G-PROTEIN (family, +,-) -> ENZYMES (adenylyl cyclase, guanylyl cyclase, phospholipase I, other )->SEC MESSENGERS
(cAMP,cGMP,IP3, DAG)-> ENZYME ACTIVATION, CHANNEL
OPENING -> RESPONSE |
|
|
Term
Sequence of REC
→ TRANSMEMBRANE ENZYME |
|
Definition
|
|
Term
|
Definition
Drug binding to specific receptor |
|
|
Term
|
Definition
Drug binding to different site which then influences this receptor |
|
|
Term
|
Definition
show affinity and intrinsic activity – cause a direct response |
|
|
Term
|
Definition
cause maximum biological response |
|
|
Term
What is a partial agonist? |
|
Definition
cause less than maximum biological response, can be antagonists at high endogenous ligand activity |
|
|
Term
|
Definition
show only affinity, no direct response, block action
of endogenous compounds and reduce their actions |
|
|
Term
What are the 2 types of antagonist? |
|
Definition
Orthosteric and Allosteric |
|
|
Term
What are the two types of Orthosteric antagonist? |
|
Definition
Reversible, competitive
Irreversible, noncompetitive |
|
|
Term
What is competitive reversible AN |
|
Definition
compete with endogenous compounds for receptors and they can be competed from the receptor by increasing concentrations of the native ligand or an agonist |
|
|
Term
What is noncompetitive irreversible AN? |
|
Definition
bind covalently to receptors or allosterically and cannot be competed by increasing the concentrations of native ligands or agonists |
|
|
Term
what are the two types of allosteric AN |
|
Definition
Irreversible noncompetitive
Reversible noncompetitive |
|
|
Term
What are the two types of antagonistic actions? |
|
Definition
Chemical and physiological |
|
|
Term
What are the binding forces between ligand and receptor? |
|
Definition
Van der Waals forces (weak), ionic bonds and/or hydrogen bonds; thus mostly reversible
Covalent bond is less frequent due to its irreversibilty |
|
|
Term
What is the sequence of agonist? |
|
Definition
A + R
↔ A.R ↔ A.R* + response ↔ A + R |
|
|
Term
|
Definition
concentration of agonist or dose required to elicit half-maximal response |
|
|
Term
|
Definition
maximal response of agonist |
|
|
Term
|
Definition
|
|
Term
Is receptor activated by antagonist? |
|
Definition
|
|
Term
What law does receptor binding follow? |
|
Definition
|
|
Term
What is the law of mass action? |
|
Definition
Drug-Receptor-complexes
Drug concentration = __________________ x Constant
Number of free receptors
|
|
|
Term
What does the type of receptor determine? |
|
Definition
the specific physiological response |
|
|
Term
What does the number of receptors stimulated determine? |
|
Definition
the extent of the response |
|
|
Term
Describe the physiological response |
|
Definition
response starts above a certain threshold number of receptors; usually graded (stepwise) and shows ceiling effect when all available receptors are stimulated
Not all but a fraction of available receptors can be stimulated, remaining ones are not activated = spare receptors |
|
|
Term
True or False
Drugs with small margin of safety are safe |
|
Definition
|
|
Term
What is therapeutic index? |
|
Definition
TI = 50% Lethal Dose (LD50) / 50% Effective Dose (ED50) |
|
|
Term
What is efficacy in terms of receptor? |
|
Definition
maximal effect of a drug
(number of receptors) |
|
|
Term
|
Definition
dose which produces a specific effect
(affinity of drug to receptor) |
|
|
Term
Describe the bell-shaped curve of the effects of a drug in a group of patients? |
|
Definition
Most individuals fall within narrow dose range (or the median) while very few individuals fall outside |
|
|
Term
How are the structure and number of receptors determined in a person? |
|
Definition
Genetically; also influenced by diseases, endogenous compounds or drugs |
|
|
Term
What can slight genetic variations have effect on the receptor? |
|
Definition
changes response to drugs |
|
|
Term
What effect does chronic stimulation of agonist/disease have on receptors? |
|
Definition
down-regulation, decrease in number/affinity of receptors, reduced activity of second messenger system, reduced drug sensitivity (thus higher dose needed) |
|
|
Term
What effect does chronic stimulation of antagonist/disease have on receptors?
|
|
Definition
up-regulation, increase in number/affinity of receptors, increased activity of second messenger system, increased sensitivity (thus lower dose needed) |
|
|
Term
Decribe the life of receptors |
|
Definition
Receptors develop during the early days/months/years of life (neonatal pharmacology) and decline during older age (geriatric pharmacology) |
|
|
Term
What would be the starting dose of a young and old compared to an adult? |
|
Definition
starting dose in “young” and “old” patients is usually 1/2 to 1/3 of normal adult dose |
|
|
Term
How can idiosyncratic drug responses to drug be caused? |
|
Definition
Diseases can cause receptor abnormalities, thus reducing or enhancing the number or sensitivity of receptors |
|
|
Term
How can the presence of other drugs competing for the same receptor or receptors with similar physiological responses affect the response of a given drug? |
|
Definition
increased therapeutic or toxic effect |
|
|